Crescent Biopharma
CBIO
#6946
Rank
A$1.05 B
Marketcap
A$28.32
Share price
-2.01%
Change (1 day)
N/A
Change (1 year)

Crescent Biopharma (CBIO) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$26.99 Million

According to Crescent Biopharma's latest financial reports the company's total liabilities are A$26.99 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Crescent Biopharma - Total liabilities on balance sheet (from 2025 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$55.65 M-32.24%
2024-12-31A$82.14 M